Derivation of human embryonic stem cells in defined conditions
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We have previously reported that high concentrations of basic fibroblast growth factor (bFGF) support feeder-independent growth of human embryonic stem (ES) cells, but those conditions included poorly defined serum and matrix components. Here we report feeder-independent human ES cell culture that includes protein components solely derived from recombinant sources or purified from human material. We describe the derivation of two new human ES cell lines in these defined culture conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the discovery of iPSC generation, the field has transitioned from using PSC culture media containing animal reagents to Xeno-free and even animal-free media [64,65,66].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [66]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationYing, Q.-L., Nichols, J., Chambers, I., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00847-x · Cited by 2,122
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109
Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C.-P., Harris, C. P., Waknitz, M. A., Itskovitz-Eldor, J., & Thomson, J. A. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9912 · Cited by 1,472
Self-citationBMP4 initiates human embryonic stem cell differentiation to trophoblast
Xu, R.-H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P., & Thomson, J. A. (2002) · Nature Biotechnology · doi:10.1038/nbt761 · Cited by 1,128
Self-citationRecurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
Self-citationBasic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells
Xu, R.-H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., & Thomson, J. A. (2005) · Nature Methods · doi:10.1038/nmeth744 · Cited by 973
Self-citationHuman embryonic stem cells express an immunogenic nonhuman sialic acid
Martin, M. J., Muotri, A., Gage, F., & Varki, A. (2005) · Nature Medicine · doi:10.1038/nm1181 · Cited by 932
Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1
Amit, M., Shariki, C., Margulets, V., & Itskovitz-Eldor, J. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.021147 · Cited by 664
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
Sperger, J. M., Chen, X., Draper, J. S., Antosiewicz, J. E., Chon, C. H., Jones, S. B., Brooks, J. D., Andrews, P. W., Brown, P. O., & Thomson, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235735100 · Cited by 648
Self-citation
Cited by
Items 401–500 of 1,000
Wang, L., Su, Y., Huang, C., Yin, Y., Chu, A., Knupp, A., & Tang, Y. (2019) · Biology Open · doi:10.1242/bio.047225 · Cited by 39
Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells
Stephenson, E., Ogilvie, C. M., Patel, H., Cornwell, G., Jacquet, L., Kadeva, N., Braude, P., & Ilić, D. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2010.0343.focus · Cited by 39
Preventing erosion of X-chromosome inactivation in human embryonic stem cells
Cloutier, M., Kumar, S., Buttigieg, E., Keller, L., Lee, B., Williams, A. M., Mojica-Perez, S. P., Erliandri, I., da Rocha, A. M., Cadigan, K. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30259-x · Cited by 40
Hwang, S.-T., Kang, S., Lee, S.-J., Lee, T.-H., Suh, W., Shim, S. H., Lee, D.-R., Taite, L. J., Kim, K., & Lee, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.031 · Cited by 41
“abnormal karyotype with trisomy 12 between 4 and 7 months of culture [8].”
BackgroundMethodInfluentialChen, H., Chuang, C.-Y., Shieh, Y.-K., Chang, H.-W., Ho, H., & Kuo, H. (2009) · Human Reproduction · doi:10.1093/humrep/dep003 · Cited by 39
“, 2008) or combinations of various growth factors/cytokines and extracellular matrix from human origins (Ludwig et al., 2006), have been demonstrated to be effective in supporting the long-term growth of hESCs.”
BackgroundEfthymiou, A. G., Chen, G., Rao, M. S., Chen, G., & Boehm, M. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.922533 · Cited by 44
“In the last 15 years, many laboratories have made major efforts to develop more consistent and defined hPSC culture conditions; an international consortium was formed in 2010 to evaluate popular formulas for consensus use [11,14-17].”
BackgroundInformed Consent and Federal Funding for Stem Cell Research
Streiffer, R. (2008) · The Hastings Center Report · doi:10.1353/hcr.0.0013 · Cited by 39
Development of a human iPSC-derived placental barrier-on-chip model
Lermant, A., Rabussier, G., Lanz, H. L., Davidson, L., Porter, I. M., & Murdoch, C. E. (2023) · iScience · doi:10.1016/j.isci.2023.107240 · Cited by 38
Artificial niche substrates for embryonic and induced pluripotent stem cell cultures
Joddar, B., & Ito, Y. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.04.021 · Cited by 43
Khazaei, M., Siddiqui, A. M., & Fehlings, M. G. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm4010037 · Cited by 43
“This increases the risk of graft rejection [148].”
BackgroundNowwarote, N., Pavasant, P., & Osathanon, T. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.11.017 · Cited by 38
Zhang, X., Simerly, C. R., Hartnett, C., Schatten, G. P., & Smithgall, T. E. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.09.007 · Cited by 38
“For this study, we cultured the hES cell lines H1, H7 and H9 in chemically defined mTeSR self-renewal medium under-feeder free conditions on Matrigel-coated plates (Ludwig et al., 2006).”
Menstrual Blood Stromal Cells: The Potential for Regenerative Medicine
Patel, A. N., & Silva, F. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.4.443 · Cited by 38
Challenges and Approaches to the Culture of Pluripotent Human Embryonic Stem Cells
Skottman, H., Narkilahti, S., & Hovatta, O. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.3.265 · Cited by 37
“270 using chemically defined xeno-free culture medium and a combination of human laminin, collagen IV, fibronectin and vitronectin matrix [52].”
BackgroundMethodInfluentialDefining synthetic surfaces for human pluripotent stem cell culture
Lambshead, J., Meagher, L., O’Brien, C., & Laslett, A. L. (2013) · Cell Regeneration · doi:10.1186/2045-9769-2-7 · Cited by 40
Protocol for directed differentiation of human pluripotent stem cells toward a hepatocyte fate
Cai, J. (2014) · StemBook · doi:10.3824/stembook.1.52.1 · Cited by 42
Lynch, E. M., Semrad, T., Belsito, V. S., FitzGibbons, C., Reilly, M. L., Hayakawa, K., & Suzuki, M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039552 · Cited by 38
Jiang, B., Xiang, Z., Ai, Z., Wang, H., Li, Y., Ji, W., & Li, T. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.024 · Cited by 37
“1C), and were subjected to 3D suspension propagation in mTeSR1 [20] plus with the Rock inhibitor (Y27632) and methylcellulose (Fig.”
MethodPeng, Y., Bocker, M., Holm, J., Toh, W. S., Hughes, C. S., Kidwai, F. K., Lajoie, G., Cao, T., Lyko, F., & Raghunath, M. (2012) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1560 · Cited by 40
“As an interim solution, Matrigel™ (BD Biosciences, San Jose, CA, USA) has been widely used as a commercially available ECM for the propagation of hESCs, preferably in MEF-conditioned culture medium or in chemically defined media (Xu et al., 2001; Ludwig et al., 2006).”
BackgroundMethodCurrent Technology for the Derivation of Pluripotent Stem Cell Lines from Human Embryos
Hasegawa, K., Pomeroy, J. E., & Pera, M. F. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.05.010 · Cited by 37
A large-scale proteomic analysis of human embryonic stem cells
Schulz, T. C., Swistowska, A. M., Liu, Y., Swistowski, A., Palmarini, G., Constable, S., Sherrer, E. S., Robins, A. J., Rao, M. S., & Zeng, X. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-478 · Cited by 37
“Progress has been made in defining growth factor conditions that support selfrenewal [44-46], and hESC lines have been isolated in the absence of mouse embryonic fibroblasts and in animal protein free culture conditions [47,48].”
BackgroundValbuena, D., Galán, A., Sánchez, E., Póo, M. E., Gómez, E., Sánchez‐Luengo, S., Melguizo‐Sanchis, D., García, A., Ruiz, V., Moreno, R., et al. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61038-3 · Cited by 37
Zhao, C., Lin, K., & Wang, X. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100614 · Cited by 38
Miranda, C. C., Fernandes, T. G., Pascoal, J. F., Haupt, S., Brüstle, O., Cabral, J. M. S., & Diogo, M. M. (2015) · Biotechnology Journal · doi:10.1002/biot.201400846 · Cited by 38
Lu, H.-E., Tsai, M., Yang, Y.-C., Yuan, C.-C., Wang, T., Lin, X., Tseng, C., & Hwang, S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.05.017 · Cited by 37
Embryonic Stem Cells: From Bench to Bedside
Pucéat, M., & Ballis, A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100298 · Cited by 36
“A recent report demonstrated the feasibility to derive HES cell lines under animal product-free conditions.(1) However, given the variability in the potential of differentiation of HES cell lines, one or two cell lines might not satisfy the need of clinicians.”
BackgroundOvercoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
“Since the discovery of iPSC generation, the field has transitioned from using PSC culture media containing animal reagents to Xeno-free and even animal-free media [64–66].”
BackgroundKim, J., Seandel, M., Falciatori, I., Wen, D., & Rafii, S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0379 · Cited by 37
Lu, S., Kelley, T. D., Feng, Q., Chen, A., Reuveny, S., Lanza, R., & Oh, S. K. (2013) · Regenerative Medicine · doi:10.2217/rme.13.36 · Cited by 35
Thermoresponsive Worms for Expansion and Release of Human Embryonic Stem Cells
Chen, X., Prowse, A. B. J., Jia, Z., Tellier, H., Munro, T. P., Gray, P. P., & Monteiro, M. J. (2014) · Biomacromolecules · doi:10.1021/bm401702h · Cited by 35
Defined high protein content surfaces for stem cell culture
Doran, M. R., Frith, J. E., Prowse, A. B. J., Fitzpatrick, J., Wolvetang, E. J., Munro, T. P., Gray, P. P., & Cooper-White, J. J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.015 · Cited by 37
Chen, K. G., Mallon, B. S., Johnson, K. R., Hamilton, R. S., McKay, R. D. G., & Robey, P. G. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.02.002 · Cited by 39
“2) (James et al., 2005; Ludwig et al., 2006).”
InfluentialFunctional Assays for Human Embryonic Stem Cell Pluripotency
O’Connor, M. D., Kardel, M., & Eaves, C. J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-962-8_4 · Cited by 34
Culture Conditions and Enzymatic Passaging of Bovine ESC-Like Cells
Gong, G., Roach, M. L., Jiang, L., Yang, X., & Tian, X. (2010) · Cellular Reprogramming · doi:10.1089/cell.2009.0049 · Cited by 34
“Further research is needed to compare the components secreted by different feeder cells and to test if it might be possible to use feeder-independent culture conditions for derivation bESC-like cells as was done in the mouse and human (Ludwig et al., 2006; Pease et al., 1990; Xu et al., 2001).”
Tang, C. Z., & Drukker, M. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0269-5 · Cited by 36
Expansive Generation of Functional Airway Epithelium From Human Embryonic Stem Cells
McIntyre, B. A. S., Alev, C., Mechael, R., Salci, K. R., Lee, J. B., Fiebig‐Comyn, A., Guezguez, B., Wu, Y., Sheng, G., & Bhatia, M. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0119 · Cited by 36
Human Stem Cells and Articular Cartilage Regeneration
Inui, A., Iwakura, T., & Reddi, A. H. (2012) · Cells · doi:10.3390/cells1040994 · Cited by 34
“were established for ES cells [103,104] and applied to iPS cell culture [105,106].”
MethodLarge-scale ex vivo generation of human neutrophils from cord blood CD34+ cells
Jie, Z., Zhang, Y., Wang, C., Shen, B., Guan, X., Ren, Z., Ding, X., Dai, W. H., & Jiang, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180832 · Cited by 37
Therapeutic Potentials of Human Embryonic Stem Cells in Parkinson’s Disease
Newman, M. B., & Bakay, R. A. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.02.004 · Cited by 37
“ing conditions were too rigorous and may jeopardize the integrity of hESCs genome.(76,77) Whether or not the mi-”
BackgroundHuber, B. C., Ransohoff, J. D., Ransohoff, K. J., Riegler, J., Ebert, A., Kodo, K., Gong, Y., Sánchez-Freire, V., Dey, D., Kooreman, N. G., et al. (2013) · Stem Cells · doi:10.1002/stem.1501 · Cited by 36
Thomson, A. J., Wojtacha, D., Hewitt, Z., Priddle, H., Sottile, V., Domenico, A. I. D., Fletcher, J. M., Waterfall, M., Lopez-Corrales, N. L., Ansell, R., et al. (2008) · Cloning and Stem Cells · doi:10.1089/clo.2007.0072 · Cited by 33
“Of particular note, the abnormalities in chromsomes 17q and 12 have been shown to occur on several independent occasions (Draper et al., 2004; Ludwig et al., 2006).”
Synthetic substrates for long-term stem cell culture
Ross, A. M., Nandivada, H., Ryan, A. L., & Lahann, J. (2012) · Polymer · doi:10.1016/j.polymer.2012.03.064 · Cited by 33
Long‐term expansion of human induced pluripotent stem cells in a microcarrier‐based dynamic system
Badenes, S. M., Fernandes, T. G., Miranda, C. C., Pusch‐Klein, A., Haupt, S., Rodrigues, C. A. V., Diogo, M. M., Brüstle, O., & Cabral, J. M. S. (2016) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.5074 · Cited by 32
Daniszewski, M., Nguyen, Q. H., Chy, H. S., Singh, V., Crombie, D. E., Kulkarni, T., Liang, H. H., Sivakumaran, P., Lidgerwood, G. E., Hernández, D., et al. (2018) · iScience · doi:10.1016/j.isci.2018.08.016 · Cited by 33
Hongisto, H., Vattulainen, M., Ilmarinen, T., Mikhailova, A., & Skottman, H. (2018) · Journal of Visualized Experiments · doi:10.3791/58279-v · Cited by 34
Techno-Economic Analysis of Automated iPSC Production
Nießing, B., Kiesel, R., Herbst, L., & Schmitt, R. H. (2021) · Processes · doi:10.3390/pr9020240 · Cited by 32
“When handling iPSC cultivations, a major concern is the maintenance of pluripotency, as this is highly sensitive to the cultivation conditions, such as media composition, growth surface and high cell densities [19,20].”
BackgroundVojtová, L., Pavliňáková, V., Muchová, J., Kacvinská, K., Brtníková, J., Knoz, M., Lipový, B., Faldyna, M., Göpfert, E., Holoubek, J., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9060590 · Cited by 32
“It has a positive effect on pluripotency of embryonic stem cell at cells up to 100 ng/mL while lower levels of 1–10 ng/mL are effective for other cell types [63].”
BackgroundMuok, L., Sun, L. J., Esmonde, C., Worden, H., Vied, C., Duke, L. C., Ma, S., Zeng, O. Z., Driscoll, T. P., Jung, S., et al. (2024) · Journal of Extracellular Biology · doi:10.1002/jex2.133 · Cited by 33
“The formulation of mTeSR medium was also reported previously (Ludwig et al., 2006).”
Hewitt, Z., Amps, K., & Moore, H. D. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100321 · Cited by 32
Liang, Y., Zhang, H., Feng, Q., Cai, M.-B., Deng, W., Qin, D., Yun, J., Tsao, G. S., Kang, T., Esteban, M. A., et al. (2012) · 癌症:英文版 · doi:10.5732/cjc.012.10065 · Cited by 34
Therapeutic cloning: promises and issues
Kfoury, C. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v10i2.450 · Cited by 31
Vuoristo, S., Toivonen, S., Weltner, J., Mikkola, M., Ustinov, J., Trokovic, R., Palgi, J., Lund, R., Tuuri, T., & Otonkoski, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076205 · Cited by 33
“There has been a growing interest in developing defined, serum-free culture conditions for hPSCs, based on distinct basement membrane protein coatings and defined culture media [12-15,25-27].”
BackgroundLi, J., Bardy, J., Yap, L., Chen, A., Nurcombe, V., Cool, S. M., Oh, S. K. W., & Birch, W. R. (2010) · Biointerphases · doi:10.1116/1.3525804 · Cited by 31
Pluripotent marker expression and differentiation of human second trimester Mesenchymal Stem Cells
Gonzalez, R., Maki, C. B., Pacchiarotti, J., Csontos, S., Pham, J., Slepko, N., Patel, A. N., & Silva, F. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.033 · Cited by 31
Chang, C.-Y., Ting, H.-C., Liu, C.-A., Su, H.-L., Chiou, T., Harn, H., & Lin, S. (2018) · Cell Transplantation · doi:10.1177/0963689718775406 · Cited by 33
Houghton, F. D. (2021) · Reproduction · doi:10.1530/rep-20-0322 · Cited by 38
Engineered microenvironments for human stem cells
Godier-Furnémont, A., Marolt, D., Gerecht, S., Tajnšek, U., Martens, T. P., & Vunjak‐Novakovic, G. (2008) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20138 · Cited by 37
“…for the attachment of hESC colonies (such as those consisting of extracellular matrix proteins: laminin, fibronectin, vitronectin) (Xu et al., 2001; Ludwig et al., 2006; Braam et al., 2008); (ii) regulatory molecules, produced by the feeder layer cells as paracrine factors and/or supplemented in…”
InfluentialHoof, D. V., Braam, S. R., Dormeyer, W., Oostwaard, D. W., Heck, A. J. R., Krijgsveld, J., & Mummery, C. L. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0365 · Cited by 31
Xi, J., Wang, Y., Zhang, P., He, L., Nan, X., Yue, W., & Pei, X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014457 · Cited by 31
“And several chemically defined culture mediums also are used to maintain hES cells [17,19,34].”
BackgroundPratumkaew, P., Issaragrisil, S., & Luanpitpong, S. (2021) · Cells · doi:10.3390/cells10113250 · Cited by 32
Corradetti, B., Freile, P., Pells, S., Bagnaninchi, P., Park, J. Y., Fahmy, T. M., & Sousa, P. A. D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.011 · Cited by 30
“This becomes costly during prolonged culture over weeks and months, especially when there is a requirement for complex cocktails of protein factors to expand or direct differentiation of cells to a specific endpoint [1,2], as for example during directed differentiation of human embryonic stem cells (hESC) populations…”
BackgroundSmagghe, B. J., Stewart, A. K., Carter, M. G., Shelton, L. M., Bernier, K. J., Hartman, E. J., Calhoun, A. K., Hatziioannou, V. M., Lillacci, G., Kirk, B. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058601 · Cited by 32
Homologous Recombination in Rat Germline Stem Cells1
Kanatsu‐Shinohara, M., Kato‐Itoh, M., Ikawa, M., Takehashi, M., Sanbo, M., Morioka, Y., Tanaka, T. S. T., Morimoto, H., Hirabayashi, M., & Shinohara, T. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.090837 · Cited by 31
“Considering that a similar observation was also reported for human ES cells [47], it is possible that serum contains some unidentified factor that maintains chromosomal stability.”
BackgroundLiu, Y., Charles, L. F., Zarembinski, T. I., Johnson, K. I., Atzet, S. K., Wesselschmidt, R. L., Wight, M. E., & Kuhn, L. T. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200043 · Cited by 30
Directing human embryonic stem cells to generate vascular progenitor cells
Bai, H., & Wang, Z. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303005 · Cited by 33
Stephenson, E., Braude, P., & Mason, C. (2006) · Regenerative Medicine · doi:10.2217/17460751.1.6.739 · Cited by 30
“et al. (2006) Frozen - - 5 G3 series Vitrolife - 5 - 2 - [ 43 ]”
Pluripotent human stem cell lines: what we can learn about cancer initiation
Werbowetski‐Ogilvie, T. E., & Bhatia, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.005 · Cited by 32
Important precautions when deriving patient-specific neural elements from pluripotent cells
Parsons, X. H., Teng, Y. D., & Snyder, E. Y. (2009) · Cytotherapy · doi:10.3109/14653240903180092 · Cited by 29
“Although several human feeder, feeder-free and even chemically defined culture systems have been suggested for hESC [73–77], the Parsons et al.”
BackgroundJiang, T., Ji, F., Liu, B., Wang, F., Dong, F., & Zhu, Y. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.069 · Cited by 29
“Autografts of iPS cells may not cause immunologic rejection; ironically, this will also cause possible neoplasm formation to escape from immune surveillance (Ludwig et al., 2006; Yamanaka, 2009), ethical and political concerns have limited the use of fetal stem cells and ES cells.”
BackgroundGualandi, C., Bloise, N., Mauro, N., Ferruti, P., Manfredi, A., Sampaolesi, M., Liguori, A., Laurita, R., Gherardi, M., Colombo, V., et al. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600061 · Cited by 31
Chavez, S. L., Meneses, J. J., Nguyen, H. N., Kim, S. K., & Pera, R. A. R. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0216 · Cited by 33
“In addition, numerous studies have evaluated various feeder-free culture methods in which hESCs were plated on extracellular matrices prepared from MEFs, recombinant sources, or human material and cultured in medium that contained only human-derived recombinant proteins or a high concentration of bFGF [12,18–24].”
Engineered Microenvironments for Self-Renewal and Musculoskeletal Differentiation of Stem Cells
Hwang, Y., Phadke, A., & Varghese, S. (2011) · Regenerative Medicine · doi:10.2217/rme.11.38 · Cited by 32
Developments in cell culture systems for human pluripotent stem cells
Liu, W., Deng, C., Godoy-Parejo, C., Zhang, Y., & Chen, G. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i11.968 · Cited by 32
Hua, Y., Yoshimochi, K., Li, J., Takekita, K., Shimotsuma, M., Li, L., Qu, X., Zhang, J., Sawa, Y., Liu, L., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02879-z · Cited by 29
“However, considering that cells in AK02N and ON2 did not have the above abnormality under the same conditions, we speculate that the lower pluripotency of cells in E8 was related to the lack of albumin, which was in both AK02N and ON2 (Additional file 1: Table S1).”
BackgroundInfluentialBadur, M. G., Zhang, H., & Metallo, C. M. (2015) · Biotechnology Journal · doi:10.1002/biot.201400749 · Cited by 33
“Since the initial isolation and expansion of hESC lines on feeder layer conditions [1], more recently developed, chemically-defined culture conditions have become commonly used for the isolation and culture of hESCs and induced pluripotent stem cells (iPSCs) [2].”
BackgroundHansen, A., Mjoseng, H. K., Zhang, R., Kalloudis, M., Koutsos, V., Sousa, P. A. D., & Bradley, M. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300489 · Cited by 28
A systems biology pipeline identifies regulatory networks for stem cell engineering
Kinney, M. A., Vo, L. T., Frame, J. M., Barragan, J., Conway, A. J., Li, S., Wong, K., Collins, J. J., Cahan, P., North, T. E., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0159-2 · Cited by 28
“However, even the most-studied form of reprogramming, induced pluripotency, remains exquisitely sensitive to culture conditions and relies on signaling molecules, such as bFGF 46 .”
BackgroundHisamatsu-Sakamoto, M., Sakamoto, N., & Rosenberg, A. S. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0744 · Cited by 29
Rebuzzini, P., Pignalosa, D., Mazzini, G., Liberto, R. D., Coppola, A., Terranova, N., Magni, P., Redi, C. A., Zuccotti, M., & Garagna, S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22908 · Cited by 28
“…20 and X in hESCs) may confer, in vitro, a selective advantage and/or a higher growth rate to those cells carrying these mutations (Liu et al., 1997; Brimble et al., 2004; Draper et al., 2004; Mitalipova et al., 2005; Imreh et al., 2006; Ludwig et al., 2006; for a review seeRebuzzini et al., 2011).”
BackgroundOxygen modulates human embryonic stem cell metabolism in the absence of changes in self-renewal
Harvey, A. J., Rathjen, J., Yu, L. J., & Gardner, D. K. (2014) · Reproduction Fertility and Development · doi:10.1071/rd14013 · Cited by 30
MacIntyre, D. A., Melguizo‐Sanchis, D., Jiménez, B., Moreno, R., Stojković, M., & Pineda‐Lucena, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016732 · Cited by 29
“After 24 h the media was replaced with TeSR-1 media [39].”
MethodiPS Cells—The Triumphs and Tribulations
Sharma, R. (2016) · Dentistry Journal · doi:10.3390/dj4020019 · Cited by 27
“James Thomson, the lead researcher behind the mTeSRTM1 formula [29,30] and contains a minimized set of the components required for maintenance of hiPSCs, providing a simpler medium.”
BackgroundPeiffer, I., Barbet, R., Zhou, Y.-P., Ml, L., Monier, M., Hatzfeld, A., & Hatzfeld, J. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0279 · Cited by 27
“Xenogenic cell feeder layers have been replaced by human cell feeders [10–20] or by extracellular matrices such as xenogenic matrigel [10,21,22] or defined ECM [22–27].”
InfluentialHuman Embryonic Stem Cells: Derivation, Maintenance and Cryopreservation
Lee, J. E., & Lee, D. R. (2011) · International Journal of Stem Cells · doi:10.15283/ijsc.2011.4.1.9 · Cited by 34
“lished in these culture conditions (55).”
Distinct profiles of human embryonic stem cell metabolism and mitochondria identified by oxygen
Lees, J. G., Rathjen, J., Sheedy, J. R., Gardner, D. K., & Harvey, A. J. (2015) · Reproduction · doi:10.1530/rep-14-0633 · Cited by 32
Derivation of human embryonic stem cell lines, towards clinical quality
Hovatta, O. (2006) · Reproduction Fertility and Development · doi:10.1071/rd06075 · Cited by 27
Clinically failed eggs as a source of normal human embryo stem cells
Sousa, P. A. D., Gardner, J., Sneddon, S., Pells, S., Tye, B. J., Dand, P., Collins, D. M., Stewart, K., Shaw, L., Przyborski, S. A., et al. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.01.002 · Cited by 27
“matrix proteins (laminin, fibronectin, vitronectin, collagen IV; Ludwig et al., 2006) or in StemPro hESC serum-free medium on feeders or CELLstart matrix (Invitrogen).”
BackgroundInfluentialCulture of mouse embryonic stem cells on photoimmobilized polymers
Konno, T., Kawazoe, N., Chen, G., & Ito, Y. (2006) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.102.304 · Cited by 27
Kapucu, F. E., Vinogradov, A., Hyvärinen, T., Ylä‐Outinen, L., & Narkilahti, S. (2022) · Scientific Data · doi:10.1038/s41597-022-01242-4 · Cited by 28
Regenerative Chemical Biology: Current Challenges and Future Potential
Ao, A. S., Hao, J., & Hong, C. C. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.03.011 · Cited by 26
“Instead, pluripotin blocked two major differentiation-inducing pathways, i.e., MEK-ERK and Ras-GAP signaling (Johnson and Lapadat, 2002; Lypowy et al., 2005).”
BackgroundRamos–Mejía, V., Fernández, A. F., Ayllón, V., Real, P. J., Bueno, C., Anderson, P. O., Martín, F., Fraga, M. F., & Menéndez, P. R. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0400 · Cited by 26
Gstraunthaler, G. J. A., Rauch, C., Wechselberger, J., & Feifel, E. (2014) · Journal of Advanced Biotechnology and Bioengineering · doi:10.12970/2311-1755.2014.02.01.1 · Cited by 26
“In this context, considerable efforts are undertaken to grow human embryonic and adult stem cells under strict xeno-free culture conditions to eliminate or reduce the risk of adverse side effects due to FBS constituents [25-32].”
BackgroundSmall Molecules for Cell Reprogramming and Heart Repair: Progress and Perspective
Xie, M., Cao, N., & Ding, S. (2014) · ACS Chemical Biology · doi:10.1021/cb400865w · Cited by 29
Cytoplasmic and Nuclear TAZ Exert Distinct Functions in Regulating Primed Pluripotency
Zhou, X., Chadarevian, J. P., Ruiz, B. I., & Ying, Q. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.07.019 · Cited by 28
“mTeSR-1 is a serum-free hESC culture medium supplemented with bFGF and TGFb (Ludwig et al., 2006).”
InfluentialPrathalingam, N., Ferguson, L., Young, L., Lietz, G., Oldershaw, R. A., Healy, L. E., Craig, A., Lister, H., Binaykia, R., Sheth, R., et al. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt103 · Cited by 29
“Interestingly, the two lines derived under these conditions acquired karyotypic abnormalities during subsequent culture [5].”
BackgroundHuman Embryonic Stem Cells: the Battle Between Self-Renewal and Differentiation
Darr, H., & Benvenisty, N. (2006) · Regenerative Medicine · doi:10.2217/17460751.1.3.317 · Cited by 26
Garreta, E., Melo, E., Navajas, D., & Farré, R. (2014) · Physiological Reports · doi:10.14814/phy2.12075 · Cited by 27
“Low oxygen tension favors the establishment of new mouse and human ESC lines from blastocysts (Ludwig et al. 2006; Wang et al. 2006).”
BackgroundHigh-Content Imaging-Based Screening of Microenvironment-Induced Changes to Stem Cells
Vega, S. L., Liu, E., Patel, P. J., Kulesa, A. B., Carlson, A. L., Ma, Y., Becker, M. L., & Moghe, P. V. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112453853 · Cited by 26
“previously described.(17) For immunostaining and high-content imaging studies, clusters of hESCs or iPSCs were passaged with dispase and plated in mTeSR-1 media onto LabTek (Nunc, Naperville, IL) multiwell chambers.”
MethodMoore, H. D. M. (2006) · Nature Biotechnology · doi:10.1038/nbt0206-160 · Cited by 26
Human Embryonic Stem Cells: Lessons from Stem Cell Niches in vivo
Bendall, S. C., Stewart, M. H., & Bhatia, M. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.3.365 · Cited by 25
Metadata
- Authors
- Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., Llanas, R. A., & Thomson, J. A.
- Affiliations
- WiCell (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Thomson, James A
- Venue
- Nature Biotechnology
- Published
- 2006-01-01
- Volume
- 24
- Issue
- 2
- Pages
- 185-187
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2038723730
- Cited by
- 1,114
- References
- 15
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 20 · 2023: 25 · 2022: 26 · 2021: 28 · 2020: 31 · 2019: 31 · 2018: 34 · 2017: 48 · 2016: 39 · 2015: 55 · 2014: 65 · 2013: 80 · 2012: 85
- FWCI
- 43.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r24rr017721-04)
- U.S. Public Health Service (P20-GMO69981)
- National Center for Research Resources (R24-RR017721)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- human embryonic stem cells, defined culture conditions, basic fibroblast growth factor, recombinant growth factors, stem cell derivation, stem cell lines, serum-free culture
- MeSH terms
- Cell Differentiation, Cell Line, Cell Survival, Culture Media, Humans, Stem Cells, Cell Culture Techniques, Tissue Engineering, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.